Lens-Based Myopia Control: Know When to Treat and Expect Results
WEBDec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
Optometry in 2024: What to Expect for the New Year
WEBDecember 21, 2023. If optometry in 2024 is anything like what we’ve witnessed in 2023, it could prove to be a year filled with innovative therapies for dry eye disease (DED), legislative victories, and new ways of comanaging geographic atrophy (GA). While optometrists have many reasons to celebrate, some events may cloud what has, for the ...
SLT Gains Traction as a First-Line Glaucoma Treatment
WEBMay 10, 2024. Open-angle glaucoma prevalence is projected to rise over the next quarter century, and optometrists, particularly those practicing in states that allow them to perform laser procedures, are finding that selective laser trabeculoplasty (SLT) is gaining first-line treatment status. 1 Although topical ocular hypotensive eye drops ...
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
WEBNovember 22, 2023. As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug ...
Multifocals for Myopia Management – More Than Meets the Eye
WEBDec 10, 2021 · Low dose atropine drops, orthokeratology and multifocal contact lenses have all demonstrated success with reducing the rate of myopia progression and in reducing the axial length of the eye. 1-3 Recently, a lens with a multifocal lens design has been approved for the management of myopia progression, the …
2022: A Year of Triumphs and Breakthroughs in Optometry
WEBDec 22, 2022 · Optometry Advisor looks back at some of the top stories of 2022. In 2022, optometrists saw legislative victories in Virginia — where optometrists can now perform YAG laser capsulotomies, selective laser trabeculoplasties, and laser peripheral iridotomies — and Colorado — where ODs can now perform those …
Optometry Dx: The Roadmap to Relief - Optometry Advisor
WEBMar 11, 2022 · Optometry Dx: The Roadmap to Relief. Figure 3. This photo shows our patient 4 days after starting treatment. The staining seen earlier had resolved as had her pain, and the defect was healing. Figure 1. This image shows a 66-year-old patient’s clinical presentation under white light.
Presbyopia Drops in the Pipeline for 2023 - Optometry Advisor
WEBDec 9, 2022 · Presbyopia Drops in the Pipeline for 2023. Topical eye drops are used to treat myriad ocular surface conditions in optometry, but their use as means of managing presbyopia is a novel concept. Michael Dittman, OD, discusses some of the potential advantages of using pilocarpine drops for presbyopia management and the potential benefits of some ...
Diffusion Optics Technology Spectacles Show Superior Myopia …
WEBOct 19, 2023 · Lenses with diffusion optics technology are superior to single vision lenses for slowing pediatric myopia after 4 years of wear, according to a paper presented at the American Academy of Optometry meeting, October 11th to 14th, held in New Orleans. “It has been well-established that eye growth and refractive development is a visually-guided process and that manipulation of retinal image ...
Suspended, Translating Contact Lens Improves Vision in Patients …
WEBNov 2, 2022 · A novel soft, suspended translating contact lens provides excellent near visual acuity (VA) and adequate comfort for patients with presbyopia, according to research presented at the American Academy of Optometry 2022 annual meeting, held in San Diego, CA from October 26 to 29. Melissa Bailey, OD, …
Skip to content